rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Haya Taitel

Director

Company insider

Files Form 4 as: Director, Entera Bio.

Every Form 4 they filed

In numbers

Trades disclosed
17
Buys
4
Sells
0
Bought
$49K
Sold
$0
Companies
1
Companies where not an officer
1
First trade
22 Aug 2023
Last trade
7 Aug 2026
Last filed
7 Aug 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
ENTX Entera BioDirector · Biotechnology · last 7 Aug 20264 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
01Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
7 Aug 2026filed 7 Aug 2026ENTX Entera BioBiotechnologySEC FORM 4 Code A—20,790 at $0.00filing
7 Aug 2026filed 7 Aug 2026ENTX Entera BioBiotechnologySEC FORM 4 Code A—20,790 at $0.00filing
10 Feb 2026filed 11 Feb 2026ENTX Entera BioBiotechnologySEC FORM 4 Bought$11K7,500 at $1.48filing
10 Feb 2026filed 11 Feb 2026ENTX Entera BioBiotechnologySEC FORM 4 Bought$11K7,500 at $1.48filing
1 Jan 2026filed 2 Jan 2026ENTX Entera BioBiotechnologySEC FORM 4 Code A—26,329 at $0.00filing
1 Jan 2026filed 2 Jan 2026ENTX Entera Biooption or derivative · BiotechnologySEC FORM 4 Code A—33,505 at $0.00filing
1 Jan 2026filed 2 Jan 2026ENTX Entera Biooption or derivative · BiotechnologySEC FORM 4 Code A—33,505 at $0.00filing
1 Jan 2026filed 2 Jan 2026ENTX Entera BioBiotechnologySEC FORM 4 Code A—26,329 at $0.00filing
15 Jan 2025filed 17 Jan 2025ENTX Entera Biooption or derivative · BiotechnologySEC FORM 4 Code A—28,509 at $0.00filing
15 Jan 2025filed 17 Jan 2025ENTX Entera BioBiotechnologySEC FORM 4 Code A—6,922 at $0.00filing
2 Oct 2024filed 4 Oct 2024ENTX Entera BioBiotechnologySEC FORM 4 Code A—7,278 at $0.00filing
27 Aug 2024filed 29 Aug 2024ENTX Entera BioBiotechnologySEC FORM 4 Code A—15,335 at $0.00filing
12 Jan 2024filed 16 Jan 2024ENTX Entera BioBiotechnologySEC FORM 4 Bought$9,4059,500 at $0.99filing
10 Jan 2024filed 11 Jan 2024ENTX Entera BioBiotechnologySEC FORM 4 Bought$5,8647,615 at $0.77filing
1 Jan 2024filed 3 Jan 2024ENTX Entera Biooption or derivative · BiotechnologySEC FORM 4 Code A—108,333 at $0.00filing
13 Sep 2023filed 14 Sep 2023ENTX Entera Biooption or derivative · BiotechnologySEC FORM 4 Code A—33,368 at $0.00filing
22 Aug 2023filed 24 Aug 2023ENTX Entera BioBiotechnologySEC FORM 4 Bought$11K18,000 at $0.62filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care4

Buys in green, sells in red, by the company’s sector.

Related people

Gregory BurshteinChief of R&D · Chief of R&D at Entera Bio, filing Form 4 there in the last year
Steven D. RubinDirector · Director at Entera Bio, filing Form 4 there in the last year
Geno J. GermanoDirector · Director at Entera Bio, filing Form 4 there in the last year
Yonatan MalcaDirector · Director at Entera Bio, filing Form 4 there in the last year
Dana Yaacov-GarbeliChief Financial Officer · Chief Financial Officer at Entera Bio, filing Form 4 there in the last year